For companies the Physics on Demand program offers opportunities to strengthen their R&D power with innovations and facilities of the Amsterdam universities. With this program specific scientific expertise, equipment and state-of-the-art research facilities are made available through collaborative partnerships.
In addition we offer the Research Facilities database via which companies have access to high-end equipment, research instruments and expertise for their R&D activities.
Reach out to one of our business developers if this sounds interesting to you.
For researchers who want to collaborate with industrial partners the IXAnext program provides the Physics2Market Grant. This grant is meant for situations in which companies need further prove that a science based concept or technique can have a practical application before they agree on cooperating. It helps researchers to validate physics-related research and encourages knowledge utilization.
The total available budget is € 250,000. Researchers can apply projects, in the extension of their research, with a budget between 10 and 35k€. There is no deadline; application is possible continuously. IXA will award the Physics2Market Grant to researchers as long as the budget is available.
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]News
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]News
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]News